< Terug naar vorige pagina

Publicatie

Histone Deacetylase 6 Brain PET in Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder

Tijdschriftbijdrage - Tijdschriftartikel

Korte inhoud:OBJECTIVE: [18F]EKZ-001 is a positron emission tomography (PET) tracer targeting histone deacetylase 6 (HDAC6), an enzyme responsible for intracellular transport and clearance of misfolded proteins. HDAC6 modulation is a promising treatment strategy in neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS). Apart from motor symptoms, people with ALS (pwALS) can show a variable degree of cognitive impairment as part of the ALS-frontotemporal spectrum disorder (ALS-FTSD). This work assessed [18F]EKZ-001 binding in pwALS with variable involvement of FTSD. METHODS: Twenty-four pwALS (13M/11F, 61 ± 10 years) and 12 healthy controls (HC) (6M/6F, 58 ± 3 years) were included. Thirteen pwALS were cognitively normal (ALS-CN), and eleven pwALS presented with FTSD (ALS-FTSD) ranging from mild cognitive or behavioral impairment to FTD, according to their performance on the Edinburgh cognitive and behavioral ALS screen (ECAS). All subjects underwent dynamic PET-MR imaging with arterial sampling, and regional distribution volumes (VT) were calculated using a Logan graphical analysis. RESULTS: [18F]EKZ-001 VT was significantly lower in pwALS compared to HC. For ALS-CN, the largest reduction was found in the brainstem. For ALS-FTSD, reductions were more widespread in both gray and white matter. No differences in VT were found between pwALS with and without a C9orf72 mutation. [18F]EKZ-001 VT was not correlated with ECAS scores, age, or disease duration. INTERPRETATION: [18F]EKZ-001 binding is lower throughout the brain in pwALS compared to HC. This may be related to a compensatory mechanism to repair intracellular transport defects in ALS or to reduced HDAC6 enzyme availability for [18F]EKZ-001 binding due to sequestration of HDAC6 within protein aggregates.
Gepubliceerd in: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
ISSN: 2328-9503
Issue: 7
Volume: 12
Pagina's: 1350 - 1359
Jaar van publicatie:2025
Trefwoorden:Neurowetenschappen en Psychofarmacologie, Psychiatrie en neurologie
Toegankelijkheid:Open
Reviewstatus:Peerreview